Daniel Chevallard
Overview
Daniel Chevallard received an average of $1M in total compensation, including $393K in salary, at Sunesis Pharmaceuticals between 2020 and 2021.
Source: SEC filing on April 27, 2022.
Related executives
We found 14 more executives who work or worked at Sunesis Pharmaceuticals.
Ivor Royston
Sunesis Pharmaceuticals
Chief Executive Officer
Lisa Rojkjaer
Sunesis Pharmaceuticals
Chief Medical Officer
Par Hyare
Sunesis Pharmaceuticals
Chief Executive Officer
Judith Fox
Sunesis Pharmaceuticals
Chief Scientific Officer
William Quinn
Sunesis Pharmaceuticals
Chief Financial Officer
Dayton Misfeldt
Sunesis Pharmaceuticals
Chief Executive Officer
Daniel Swisher
Sunesis Pharmaceuticals
Chief Executive Officer
Eric Bjerkholt
Sunesis Pharmaceuticals